Fetomaternal alloimmune thrombocytopenia
Template:Fetomaternal alloimmune thrombocytopenia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
In fetomaternal alloimmune thrombocytopenia (also known as Neonatal Alloimmune Thrombocytopenia or NAIT) maternal IgG antibodies (specific for platelet antigens) pass through the placenta and attack platelets in the fetal circulation. This results in the fetus having low numbers of platelets and a tendency for the fetus or neonate to bruise and bleed. Medical treatment is problematic.
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fetomaternal alloimmune thrombocytopenia from other Diseases
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies Template:WH Template:WikiDoc Sources